The purpose of this guideline is to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for cancer treatment to patient needs if services become limited because of the COVID-19 pandem...
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Clinical Diagnosis/diagnosis,
Betacoronavirus/drug effects,
Coronavirus Infections/diagnosis,
Pneumonia, Viral/diagnosis,
Hypoxia/diagnosis,
Patient Acuity,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Dexamethasone/therapeutic use,
Breast Feeding,
Antiviral Agents/therapeutic use,
Hydroxychloroquine/therapeutic use,
Colchicine/therapeutic use,
Plasma/immunology,
Darunavir/therapeutic use,
Interferons/therapeutic use,
Evidence-Based Practice/methods
Multiple questions have been raised regarding the gastrointestinal and liver manifestations of COVID-19 infection, and implications of SARS-CoV-2 infection on gastrointestinal endoscopy. A joint society statement of the American Gastroenterological Association (AGA), the American Association for the Stud...
Chronic pain patients require continuity of care even during the COVID-19 pandemic, which has drastically changed healthcare and other societal practices. The American Society of Interventional Pain Physicians (ASIPP) has created the COVID-ASIPP Risk Mitigation and Stratification (COVID-ARMS) Return to P...
Coronavirus Infections/complications,
Betacoronavirus,
Risk Factors,
Cardiovascular Diseases/complications,
Hypertension,
Diabetes Mellitus,
Obesity,
Steroids,
Pain Management,
Chronic Disease,
Pneumonia, Viral/complications
